Research Paper Volume 14, Issue 22 pp 8927—8943
The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study
Figure 1. Prevalence of delirium by comparing three patient groups based on their DM status and history of metformin use. The Chi-square test corrected by Holm method showed significant difference between non-DM group and DM-without-metformin group (p=0.048).